Uncover Therapeutics is developing a first-in-class cancer immunotherapy designed to transform tumors' immune-suppressive shield into an immune-activating beacon. The therapy combines checkpoint inhibition with targeted immune activation to reactivate and expand the immune response, aiming for deeper and more durable anti-tumor effects in solid tumors. The lead asset is approximately 12-15 months from regulatory submission for first-in-human trials.
Funding
Funding not disclosed
Founders
Product
Problem
While immunotherapy has transformed outcomes for some cancer patients, the majority still do not benefit, representing one of the largest unmet needs in oncology. Current immune-oncology therapies are limited in their ability to overcome the immune-suppressive mechanisms that solid tumors use to evade detection and attack.
Solution
Uncover Therapeutics is advancing a potential first-in-class therapy designed to overcome the key limitations of current immune-oncology approaches. The therapy combines checkpoint inhibition with targeted immune activation, engineered to transform cancer's immune shield into an immune beacon that reactivates and expands the immune response. Supported by compelling preclinical data, the lead asset is approximately 12-15 months from regulatory submission to enable first-in-human clinical trials in solid tumors. The approach aims to unlock deeper and more durable anti-tumour responses than existing immunotherapies.
Target Audience
Primary stakeholders are oncology researchers, clinical development teams, and potential pharmaceutical partners focused on advancing novel immunotherapies for solid tumor indications.
Features
- First-in-class mechanism combining checkpoint inhibition with targeted immune activation
- Designed to convert tumor immune evasion into an immune-stimulatory signal
- Compelling preclinical data supporting advancement toward clinical development
- Lead asset positioned for regulatory submission within 12-15 months
- Focus on solid tumors, addressing a significant unmet medical need